129
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Hearing status in patients with vitiligo

, , , &
Pages 445-450 | Published online: 21 Jun 2019

References

  • Mirnezami M, Rahimi H. Serum zinc level in patients with vitiligo: a case-control study. Indian J Dermatol. 2018;63;227–230.29937559
  • Zokaei S, Farhud DD, Keykhaei M, et al. Cultured epidermal melanocyte transplantation in vitiligo: a review article. Iran J Public Health. 2019;3:388–399.
  • Goldgeie MH, Klein LE, Klein-Angerer S, et al. The distribution of melanocyte in the leptomeninges of the human brain. J Invest Dermatol. 1984;82:235–238.6699426
  • Araki S, Mizuta K, Takeshita T, et al. Degeneration of the stria vascularis during development in melanocyte deficient mutant rats (Ws/Ws rats). Eur Arch Otorhinolaryngol. 2002;259:309–315.12115079
  • Ardiç FN, Aktan S, Kara CO, Sanli B. High-frequency hearing and reflex latency in patients with pigment disorder. Am J Otolaryngol. 1998;19:365–369.9839910
  • Conlee JW, Bennett ML, Creel DJ. Differential effects of gentamicin on the distribution of cochlear function in albino and pigmented guinea pigs. Acta Otolaryngol. 1995;115:367–374.7653256
  • Tachibana M. Sound needs sound melanocytes to be heard. Pigment Cell Res. 1999;12:344–354.10614574
  • Steel KP, Barkway C. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development. 1989;107:453–463.2612372
  • Nin F, Yoshida T, Sawamura S, et al. The unique electrical properties in an extracellular fluid of the mammalian cochlea; their functional roles, homeostatic processes, and pathological significance. Pflugers Arch. 2016;468:1637–1649. doi:10.1007/s00424-016-1871-027568193
  • Prieve B, Fitzgerald S. Otoacoustic emissions In: Katz J, editor. Handbook of Clinical Audiology. Baltimore, MD: Lippincot Williams and Wilkins; 2003:440–460.
  • Brown AM, McDowell B, Forge A. Acoustic distortion product can be used to monitor the effects of chronic gentamicin treatment. Hear Res. 1989;42:143–156. doi:10.1016/0378-5955(89)90140-82606800
  • Vinck BM, Van Cauwenberge PB, Leroy L, Corthals P. Sensitivity of transient evoked and distortion product otoacoustic emissions to direct effects of noise on the human cochlear. Audiology. 1999;38:44–52. doi:10.3109/0020609990907300110052835
  • De Jong MA, Adelman C, Gross M. Hearing loss in vitiligo: current concepts and review. Eur Arch Otorhinolaryngol. 2017;274:2367–2372. doi:10.1007/s00405-017-4452-828197707
  • Orecchia G, Marelli MA, Fresa D, Robiolio L. Audiologic disturbances in vitiligo. J Am Acad Dermatol. 1989;21:1317–1318.
  • Ozüer MZ, Sahiner T, Aktan S, Sanli B, Bayramoğlu I. Auditory evoked potentials in vitiligo patients. Scand Audiol. 1998;27:255–258.9832408
  • Al-Mutairi N, Al-Sebeih KH. Late onset vitiligo and audiological abnormalities: is there any association? Indian J Dermatol Venereol Leprol. 2011;77(5):571–576. doi:10.4103/0378-6323.8405921860155
  • Escalante-Ugalde C, Poblano A, Montes de Oca E, et al. No evidence of hearing loss in patients with vitiligo. Arch Dermatol. 1991;127:1240. doi:10.1001/archderm.1991.01680070142026
  • Fleissig E, Gross M, Ophir I, et al. Risk of sensorineural hearing loss in patients with vitiligo. Audiol Neurootol. 2013;18:240–246. doi:10.1159/00035033723838605
  • Arya R, Kumar Munjal S, Panda NK, Prasad D. Audiological and electrophysiological changes in patients with vitiligo. Indian J Otolaryngol Head Neck Surg. 2016;68:417–423. doi:10.1007/s12070-015-0889-527833865
  • Aslan S, Serarslan G, Teksoz E, Dagli S. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo. Otolaryngol Head Neck Surg. 2010;142:409–414. doi:10.1016/j.otohns.2009.11.00720172390
  • Abad S, Wieërs G, Colau D, et al. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient. Mol Vis. 2014;20:956–969.24991188
  • Tosti A, Bardazzi F, Tosti G, Monti L. Audiologic abnormalities in cases of vitiligo. J Am Acad Dermatol. 1987;17:230–233.3624561
  • Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S. Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol. 2006;31:110–113. doi:10.1111/j.1365-2230.2005.02004.x16309498
  • Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol. 2010;24:1144–1150. doi:10.1111/j.1468-3083.2010.03605.x20202047
  • Sharma L, Bhawan R, Jain RK. Hypoacusis in vitiligo. Indian J Dermatol Venereol Leprol. 2004;70:162–164.17642597
  • Hong CK, Lee MH, Jeong KH, Cha CI, Yeo SG. Clinical analysis of hearing levels in vitiligo patients. Eur J Dermatol. 2009;19:50–56. doi:10.1684/ejd.2008.056319059822
  • Mahdi P, Rouzbahani M, Amali A, Rezaii Khiabanlu S, Kamali M. Audiological manifestations in vitiligo patients. Iran J Otorhinolaryngol. 2012;24:35–40.24303383
  • Angrisani RM, Azevedo MF, Pereira LD, et al. A study on otoacoustic emissions and supression effects in patients with vitiligo. Braz J Otorhinolaryngol. 2009;75:111–115.19488570
  • Gopal KV, Rama Rao GR, Kumar YH, Appa Rao MV, Vasudev P. Vitiligo: a part of a systemic autoimmune process.Indian. J Dermatol Venereol Leprol. 2007;73:162–165. doi:10.4103/0378-6323.32710